Optimization and validation of a micellar electrokinetic chromatographic method for the analysis of several angiotensin-II-receptor antagonists

被引:69
作者
Hillaert, S
De Beer, TRM
De Beer, JO
Van den Bossche, W
机构
[1] State Univ Ghent, Lab Pharmaceut Chem & Drug Anal, Dept Pharmaceut Anal, Fac Pharmaceut Sci, B-9000 Ghent, Belgium
[2] Sci Inst Publ Hlth Louis Pasteur, Dept Drug Anal, B-1050 Brussels, Belgium
关键词
experimental design; optimization; validation; pharmaceutical analysis; angiotensin receptor antagonists;
D O I
10.1016/S0021-9673(02)01832-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have optimized a micellar electrokinetic capillary chromatographic method for the separation of six angiotensin-II-receptor antagonists (ARA-IIs): candesartan, eprosartan mesylate, irbesartan, losartan potassium, telmisartan, and valsartan. A face-centred central composite design was applied to study the effect of the pH, the molarity of the running buffer, and the concentration of the micelle-forming agent on the separation properties. A combination of the studied parameters permitted the separation of the six ARA-IIs, which was best carried out using a 55-mM sodium phosphate buffer solution (pH 6.5) containing 15 mM of sodium dodecyl sulfate. The same system can also be applied for the quantitative determination of these compounds, but only for the more stable ARA-IIs (candesartan, eprosartan mesylate, losartan potassium, and valsartan). Some system parameters (linearity, precision, and accuracy) were validated. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 31 条
[1]   High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436 BMS-186295) in human plasma and urine [J].
Chang, SY ;
Whigan, DB ;
Vachharajani, NN ;
Patel, R .
JOURNAL OF CHROMATOGRAPHY B, 1997, 702 (1-2) :149-155
[2]  
CHEN YC, 2001, YAOWU FENXI ZAZHI, V21, P196
[3]   Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate [J].
Farthing, D ;
Sica, D ;
Fakhry, I ;
Pedro, A ;
Gehr, TWB .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :374-378
[4]   Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester [J].
Francotte, E ;
Davatz, A ;
Richert, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 686 (01) :77-83
[5]   SIMULTANEOUS DETERMINATION OF A NOVEL ANGIOTENSIN-II RECEPTOR BLOCKING-AGENT, LOSARTAN, AND ITS METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FURTEK, CI ;
LO, MW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :295-301
[6]   A high-performance liquid chromatographic method for screening angiotensin II receptor antagonists in human urine [J].
González, L ;
Alonso, RM ;
Jiménez, RM .
CHROMATOGRAPHIA, 2000, 52 (11-12) :735-740
[7]  
Guzman N.A., 1993, CAPILLARY ELECTROPHO
[8]   Optimization of an HPLC method for the separation of erythromycin and related compounds using factorial design [J].
Harang, V ;
Westerlund, D .
CHROMATOGRAPHIA, 1999, 50 (9-10) :525-531
[9]   Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists [J].
Hillaert, S ;
Van den Bossche, W .
JOURNAL OF CHROMATOGRAPHY A, 2002, 979 (1-2) :323-333
[10]   Reversed-phase ion-pair liquid chromatography of a pharmaceutical compound and its photolytically transformed isomer [J].
Hsu, LC .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1998, 21 (11) :1685-1700